Renato V LaRocca MD FACP

Oncology•Louisville, KY

Hematologic Oncology, Neuro-Oncology

Physician

Join to View Full Profile

Norton Cancer Institute676 South Floyd StreetLouisville, KY 40202
Phone+1 502-629-2485

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1985 - 1987
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1982 - 1985
Weill Cornell MedicineClass of 1982

Certifications & Licensure

KY State Medical License 1990 - 2026
IN State Medical License 1990 - 2025
VA State Medical License 1988 - 2016
MD State Medical License 1985 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
United Council for Neurologic SubspecialtiesNeuro Oncolgy

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Chest X-Ray or Chest CT Scan in Patients at High Risk of Developing Lung Cancer Start of enrollment: 1999 Nov 01
Unknown status
Not Applicable
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer Start of enrollment: 2004 May 01
Completed
Not Applicable
Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma Start of enrollment: 2002 Sep 01
Unknown status
Phase 2
High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma Start of enrollment: 2001 Aug 01
Completed
Phase 1, Phase 2
Genetic Epidemiology of Adult Onset Glioma Start of enrollment: 2004 May 01
Completed
Risk Factors for Adult-Onset Brain Tumors Start of enrollment: 2003 Oct 01
Terminated
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma Start of enrollment: 2009 Jan 01
Unknown status
Phase 2
A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma Start of enrollment: 2008 Apr 01
Unknown status
Phase 2
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
Completed
Phase 3
A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Join now to see all

Publications & Presentations

PubMed

1 citations
Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.
Sepideh Mokhtari, Noah C Peeri, Andre Beer-Furlan, Mark D Anderson, Sajeel Chowdhary
British Journal of Neurosurgery. 2025-04-01
29 citations
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment.
Daniela A Bota, Thomas H Taylor, David E Piccioni, Christopher M Duma, Renato V LaRocca
Journal of Experimental & Clinical Cancer Research. 2022-12-14
3 citations
Amplified Cardiopulmonary Recordings: Music Therapy Legacy Intervention with Adult Oncology Patients and Their Families-A Preliminary Program Evaluation.
Brian Schreck, Joanne Loewy, Renato V LaRocca, Elizabeth Harman, Elizabeth Archer-Nanda
Journal of Palliative Medicine. 2022-09-01

Press Mentions

Former WWE Superstar Matt Cappotelli Diagnosed with Brain Tumour for Second TimeDecember 12th, 2017
Brain, Body & Behaviors | How Your Smartphone Is Hacking Your Family’s HealthNovember 2nd, 2016

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
Society of Neuro Oncology
Member
European Society of Medical Oncology (ESMO)
Member

Other Languages

Italian